NCT00475215View on ClinicalTrials.gov

Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)

PHASE3CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 27, 2005

Primary Completion Date

August 21, 2006

Study Completion Date

September 9, 2006

Conditions
Anesthesia, General
Interventions
DRUG

Sugammadex

Sugammadex solution for injection.

DRUG

Rocuronium

Rocuronium bromide solution for injection.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00475215 - Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) | Biotech Hunter | Biotech Hunter